| Home | E-Submission | Sitemap | Editorial Office |  
Korean J Urol Oncol > Volume 12(3); 2014 > Article
The Korean Journal of Urological Oncology 2014;12(3): 132-136.
신혈관근지방종의 치료로 시행한 선택적동맥색전술의 장기간 치료 효과 분석
정재훈1, 문경현2, 김태효3, 이기수3, 이 완4, 김규식1, 이승욱1
1한양대학교 의과대학 비뇨기과학교실, 2울산대학교 의과대학 비뇨기과학교실, 3동아대학교 의과대학 비뇨기과학교실, 4동남권원자력병원 비뇨기과학교실
Long Term Outcome of Selective Arterial Embolization for Renal Angiomyolipoma
Jae Hoon Chung 1, Kyung Hyun Moon 2, Tae Hyo Kim 3, Ki Soo Lee 3, Wan Lee 4, Kyu Shik Kim 1, Seung Wook Lee 1
1Department of Urology, Hanyang University Guri Hospital, Guri, 2Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, 3Department of Urology, Dong-A University College of Medicine, 4Department of Urology, Cancer Center, Dongnam Institute of Radiological & Medical Science, Busan, Korea
Published online: December 30, 2014.
We evaluate the complication rates and the treatment outcome of patients treated by selective arterial embolization (SAE) for a large or symptomatic renal angiomyolipoma (AML).
Materials and Methods:
52 patients with 56 kidneys containing AML were treated by SAE. All patients were treated by SAE and followed up in multicenter. The variables used for the analysis were age, gender, presence of tuberous sclerosis (TS), and maximal tumor size prior to SAE. The study end points were recurrence of symptoms or bleeding, the need for re-embolization or surgery, and disease-specific survival. The mean follow-up period for the entire group was 6.8 year.
Mean patient age was 51.4 year and the mean initial tumor size was 8.8cm. Successful SAE was achieved in 48 cases (84.8%) with minor complication rate of 11.5%. Avoidance of surgery was achieved in 91.9% of the kidneys in five years. And avoidance of re-embolization was achieved in 67.9% in five years. No retroperitoneal hemorrhage was noted during follow-up. Disease-specific survival of the entire cohort was 100%.
SAE of renal AML has long-term efficacy in preventing hemorrhagic complications of renal AML, and preservation of the involved kidneys is amenable. (Korean J Urol Oncol 2014;12:132-136)
Key Words: Angiomyolipoma; Embolization; Therapeutic; Treatment Outcome
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
CrossRef TDM  CrossRef TDM
Related article
Editorial Office
Department of Urology, Chung-Ang University Hospital
102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-1819   Fax: +82-2-6294-1406   E-mail: journal@kjuo.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Urological Oncology Society and The Korean Prostate Society. All rights reserved.                 developed in m2community
Close layer
prev next